fda removing semaglutide The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw Semaglutide FDA Approval vs Compounded

Radiofrequency and Ultrasound Treatments Radiofrequency devices like Thermage and Exilis deliver controlled heat to stimulate collagen production and mild skin contraction

The results obtained indicate that GLP-1RAs can have neuroprotective effects, mild vasoprotective and anti-inflammatory effects, delaying the increase in intraocular pressure and preventing reactive remodeling of astrocytes and blood vessels in glaucoma

10.1530/ec-23-0284 19

Most of the research comes from animal studies, and even the researchers describe some of the effects as still unproven

We have to address this problem. In a written statement, a Lilly spokesperson said reforms in SB 282 will help protect patients from dangerous ingredients from foreign sources. Patients deserve better than untested knockoffs that are sold without clinical evidence that they are safe or even work, the statement sent by Lilly Associate Director of Public Affairs Jared Shapiro said

Insurance eligibility adds another layer